Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Study identifies multiple risk factors for type 2 diabetes, including insomnia, that need to be incorporated into diabetes prevention strategies.
Read More »Overlooked Risk Factors for Type 2 Diabetes
The Risk Factor Responsible for Half of America’s Diabetes Cases
Approximately 30% to 53% of diabetes mellitus cases in the United States can be attributed to obesity.
Read More »Doubling the Dose of Semaglutide for Weight Loss Approved
The new approval of Wegovy™ is for a current medication, semaglutide, but more than doubling the standard dose for diabetes treatment.
Read More »Tirzepatide Outperforms Insulin Glargine in HbA1c and Weight Loss
SURPASS-4 is a randomized controlled trial of tirzepatide once a week vs. insulin glargine once a day in type 2 diabetes patients with high cardiovascular risk.
Read More »Bariatric Surgery and Cardiovascular Disease
A study aims to establish whether bariatric surgery can reduce adverse cardiovascular events.
Read More »Adiposity and Fat Distribution Impact on Hypertension, Cholesterol, and Diabetes
Central adiposity shows varying effects on blood pressure, LDL cholesterol, and glycemic profile.
Read More »Tirzepatide a Potential Drug for Weight Loss
Novel dual GIP and GLP-1 receptor agonist showed promising results for both reduction in A1C and weight loss.
Read More »Doubling the Semaglutide Dose Improves Weight Loss
Lifestyle management and intervention alongside a once-weekly semaglutide dose of 2.4 mg. can lead to improved weight loss for patients with overweight or obesity.
Read More »New Weight Loss Combo
A combined pharmacological therapy showed efficacy in bodyweight reduction without lifestyle, diet, physical activity changes or surgery.
Read More »Fluctuations in Waist Circumference Linked to Cardiovascular Outcomes
Can an increase in waist circumference determine cardiovascular risk, separate from weight loss or gain?
Read More »